Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer.

We demonstrated that the CTR could provide various noninvasive clinicopathological information. A CTR of more than 75% is the factor associated with a poor prognosis and should be considered when making therapeutic plans for patients with early-stage NSCLC.